| Literature DB >> 10930105 |
A A Brandes1, L M Pasetto, F Lumachi, S Monfardini.
Abstract
Endocrine alterations are frequently found in patients undergoing treatment for CNS tumors. Careful follow-up aimed at the early detection of recurrences, with life-long monitor of hypothalamus-pituitary (HP) function, will also reveal any endocrine dysfunctions; indeed, their appropriate diagnosis and treatment may determine a significant improvement in the quality of life of these patients.Entities:
Mesh:
Year: 2000 PMID: 10930105 DOI: 10.1023/a:1006471405435
Source DB: PubMed Journal: J Neurooncol ISSN: 0167-594X Impact factor: 4.130